Administrative Supplements for the P30 Cancer Center Support Grants to Enhance Sexual Orientation and Gender Identity (SOGI) Data Collection View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

1980-2026

FUNDING AMOUNT

198147648.0 USD

ABSTRACT

Compared to heterosexual and cisgender populations, SGM populations face disparities related to cancer occurrence and outcomes, including barriers in cancer prevention, treatment, and survivorship care, and significant disparities in cancer risk factors. Despite these disparities, SGM cancer research is hampered by a lack of sexual orientation and gender identity (SOGI) data collection in clinical settings and in population-based surveillance data (especially cancer registries), and as a result, incidence, and mortality trends for SGM populations are difficult to document. The National Academies of Science, Engineering, and Medicine recently recommended that the NIH adopt standardized and parsimonious practices for collecting data on sex, gender, and sexual orientation to address these challenges. The USC/Norris Comprehensive Cancer Center (NCCC) adopted standardized data collection for SOGI during 2018 across its data systems (at the central hospital and outlying clinics), but those data are collected in optional forms in a “Social/Sexual History” tab, and to date there has been no effort to determine how complete or representative those data are. NCCC evaluates and treats cancer patients from Los Angeles County’s safety net hospital (LAC/USC), which also adopted voluntary collection of SOGI data fields in 2018. Provider training in the existence and use of SOGI data items has been provided on an ad hoc basis. To evaluate the potential utility of these data in advancing SGM research across the cancer continuum, we propose the following Specific Aims: Aim 1. Study the implementation of standardized SOGI data collection at NCCC Aim 2. Assess patient-, provider-, and clinic/organizational-level barriers and facilitators toward implementation of standardized SOGI data collection by surveying patients who did, and did not, answer SOGI questions. Aim 3. Link LAC/USC and USC/Norris records to the Los Angeles Cancer Surveillance Program (LA’s SEER Registry) and describe the intersection of patient-reported SOGI data items and Registry-based gender (Male/Female/Other/Unknown) values, as well as the burden of common cancers among gender minority cancer patients, comparing incidence, stage of disease, and survival of those patients whose SOGI was misclassified in the Registry. Aim 4. Pilot and evaluate provider training in SOGI data collection. Our ultimate goal will be to document implementation processes and identify and pilot viable solutions to support full integration and use of standardized SOGI data collection in the clinical setting to support surveillance and research. By linking data with the LA SEER registry, we will be able to document the need for including SOGI data collection in population-based cancer registries and begin to track outcomes for SGM individuals on a population basis. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=10641590

Related SciGraph Publications

  • 2022-11-23. Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2022-11-07. Interactions between folate intake and genetic predictors of gene expression levels associated with colorectal cancer risk in SCIENTIFIC REPORTS
  • 2022-10-01. Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment in ONCOGENE
  • 2022-09-27. Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer in NPJ BREAST CANCER
  • 2022-09-26. Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients in ANNALS OF SURGICAL ONCOLOGY
  • 2022-09-22. Racial differences in the association of body mass index and ovarian cancer risk in the OCWAA Consortium in BRITISH JOURNAL OF CANCER
  • 2022-09-21. Characterizing DNA methylation signatures of retinoblastoma using aqueous humor liquid biopsy in NATURE COMMUNICATIONS
  • 2022-09-19. ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer in NATURE COMMUNICATIONS
  • 2022-08-22. SCP2 variant is associated with alterations in lipid metabolism, brainstem neurodegeneration, and testicular defects in HUMAN GENOMICS
  • 2022-07-26. Large-scale manipulation of promoter DNA methylation reveals context-specific transcriptional responses and stability in GENOME BIOLOGY
  • 2022-06-21. Identification of epithelial and mesenchymal circulating tumor cells in clonal lineage of an aggressive prostate cancer case in NPJ PRECISION ONCOLOGY
  • 2022-05-26. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets in ONCOGENE
  • 2022-05-23. Management Impact of Metachronous Oligometastatic Disease Identified on 18F-Fluciclovine (Axumin™) PET/CT in Biochemically Recurrent Prostate Cancer in MOLECULAR IMAGING AND BIOLOGY
  • 2022-05-16. Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer in CURRENT ONCOLOGY REPORTS
  • 2022-04-01. Bladder cancer cells shift rapidly and spontaneously to cisplatin-resistant oxidative phosphorylation that is trackable in real time in SCIENTIFIC REPORTS
  • 2022-02-21. Beyond depression: correlates of well-being in young adult survivors of childhood cancers in JOURNAL OF CANCER SURVIVORSHIP
  • 2022-02-18. Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib in NPJ BREAST CANCER
  • 2022-02-17. Chemical reversible crosslinking enables measurement of RNA 3D distances and alternative conformations in cells in NATURE COMMUNICATIONS
  • 2022-02-02. Understanding medical mistrust and HPV vaccine hesitancy among multiethnic parents in Los Angeles in JOURNAL OF BEHAVIORAL MEDICINE
  • 2022-01-27. Geographic hotspot detection for late-stage hepatocellular carcinoma: novel approach to cancer control in CANCER CAUSES & CONTROL
  • 2022-01-09. Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2022-01-04. ASO Visual Abstract: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2021-12-18. Comprehensive epigenomic profiling of human alveolar epithelial differentiation identifies key epigenetic states and transcription factor co-regulatory networks for maintenance of distal lung identity in BMC GENOMICS
  • 2021-12-06. A host-directed macrocyclic peptide therapeutic for MDR gram negative bacterial infections in SCIENTIFIC REPORTS
  • 2021-11-15. MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma in VIRCHOWS ARCHIV
  • 2021-11-11. Deciphering intratumoral heterogeneity using integrated clonal tracking and single-cell transcriptome analyses in NATURE COMMUNICATIONS
  • 2021-11-02. Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer in ONCOGENE
  • 2021-10-30. Emerging combination immunotherapy strategies for breast cancer: dual immune checkpoint modulation, antibody–drug conjugates and bispecific antibodies in BREAST CANCER RESEARCH AND TREATMENT
  • 2021-10-27. Molecular differences between lymph nodes and distant metastases compared with primaries in colorectal cancer patients in NPJ PRECISION ONCOLOGY
  • 2021-10-23. Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancer in BRITISH JOURNAL OF CANCER
  • 2021-10-08. A careful reassessment of anthracycline use in curable breast cancer in NPJ BREAST CANCER
  • 2021-08-16. Characterizing DNA methylation signatures and their potential functional roles in Merkel cell carcinoma in GENOME MEDICINE
  • 2021-08-15. Immunohistochemical analysis of glassy cell carcinoma of the cervix reveals robust lymphocyte infiltrate and the expression of targetable inhibitory immune checkpoints in ARCHIVES OF GYNECOLOGY AND OBSTETRICS
  • 2021-07-27. Inter-eye genomic heterogeneity in bilateral retinoblastoma via aqueous humor liquid biopsy in NPJ PRECISION ONCOLOGY
  • 2021-07-19. Multi-omic profiling of primary mouse neutrophils predicts a pattern of sex- and age-related functional regulation in NATURE AGING
  • 2021-07-09. Arginine methylation promotes siRNA-binding specificity for a spermatogenesis-specific isoform of the Argonaute protein CSR-1 in NATURE COMMUNICATIONS
  • 2021-06-23. Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancer in ONCOGENE
  • 2021-06-09. Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients in SCIENTIFIC REPORTS
  • 2021-05-17. MMP-2 is a novel histone H3 N-terminal protease necessary for myogenic gene activation in EPIGENETICS & CHROMATIN
  • 2021-05-16. Targeted α-therapy in non-prostate malignancies in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2021-05-11. ER residential chaperone GRP78 unconventionally relocalizes to the cell surface via endosomal transport in CELLULAR AND MOLECULAR LIFE SCIENCES
  • 2021-04-30. Endoplasmic reticulum chaperone GRP78/BiP is critical for mutant Kras-driven lung tumorigenesis in ONCOGENE
  • 2021-04-21. Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples in CLINICAL EPIGENETICS
  • 2021-04-20. Optimized photochemistry enables efficient analysis of dynamic RNA structuromes and interactomes in genetic and infectious diseases in NATURE COMMUNICATIONS
  • 2021-04-12. Clocking cancer: the circadian clock as a target in cancer therapy in ONCOGENE
  • 2021-04-06. Urinary phthalate exposures and risk of breast cancer: the Multiethnic Cohort study in BREAST CANCER RESEARCH
  • 2021-03-25. Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk in NPJ BREAST CANCER
  • 2021-03-11. Near-Infrared Monoamine Oxidase Inhibitor Biodistribution in a Glioma Mouse Model in PHARMACEUTICAL RESEARCH
  • 2021-03-06. Evidence for racial/ethnic disparities in emergency department visits following breast cancer surgery among women in California: a population-based study in BREAST CANCER RESEARCH AND TREATMENT
  • 2021-02-25. Immunogenicity of CAR T cells in cancer therapy in NATURE REVIEWS CLINICAL ONCOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/42", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "amount": {
          "currency": "USD", 
          "type": "MonetaryAmount", 
          "value": 198147648.0
        }, 
        "description": "Abstract Compared to heterosexual and cisgender populations, SGM populations face disparities related to cancer occurrence and outcomes, including barriers in cancer prevention, treatment, and survivorship care, and significant disparities in cancer risk factors. Despite these disparities, SGM cancer research is hampered by a lack of sexual orientation and gender identity (SOGI) data collection in clinical settings and in population-based surveillance data (especially cancer registries), and as a result, incidence, and mortality trends for SGM populations are difficult to document. The National Academies of Science, Engineering, and Medicine recently recommended that the NIH adopt standardized and parsimonious practices for collecting data on sex, gender, and sexual orientation to address these challenges. The USC/Norris Comprehensive Cancer Center (NCCC) adopted standardized data collection for SOGI during 2018 across its data systems (at the central hospital and outlying clinics), but those data are collected in optional forms in a \u201cSocial/Sexual History\u201d tab, and to date there has been no effort to determine how complete or representative those data are. NCCC evaluates and treats cancer patients from Los Angeles County\u2019s safety net hospital (LAC/USC), which also adopted voluntary collection of SOGI data fields in 2018. Provider training in the existence and use of SOGI data items has been provided on an ad hoc basis. To evaluate the potential utility of these data in advancing SGM research across the cancer continuum, we propose the following Specific Aims: Aim 1. Study the implementation of standardized SOGI data collection at NCCC Aim 2. Assess patient-, provider-, and clinic/organizational-level barriers and facilitators toward implementation of standardized SOGI data collection by surveying patients who did, and did not, answer SOGI questions. Aim 3. Link LAC/USC and USC/Norris records to the Los Angeles Cancer Surveillance Program (LA\u2019s SEER Registry) and describe the intersection of patient-reported SOGI data items and Registry-based gender (Male/Female/Other/Unknown) values, as well as the burden of common cancers among gender minority cancer patients, comparing incidence, stage of disease, and survival of those patients whose SOGI was misclassified in the Registry. Aim 4. Pilot and evaluate provider training in SOGI data collection. Our ultimate goal will be to document implementation processes and identify and pilot viable solutions to support full integration and use of standardized SOGI data collection in the clinical setting to support surveillance and research. By linking data with the LA SEER registry, we will be able to document the need for including SOGI data collection in population-based cancer registries and begin to track outcomes for SGM individuals on a population basis.", 
        "endDate": "2026-11-30", 
        "funder": {
          "id": "http://www.grid.ac/institutes/grid.48336.3a", 
          "type": "Organization"
        }, 
        "id": "sg:grant.2438805", 
        "identifier": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "grant.2438805"
            ]
          }, 
          {
            "name": "nih_id", 
            "type": "PropertyValue", 
            "value": [
              "P30CA014089"
            ]
          }
        ], 
        "keywords": [
          "safety-net hospital", 
          "gender identity data collection", 
          "cancer patients", 
          "provider training", 
          "Los Angeles Cancer Surveillance Program", 
          "county safety-net hospital", 
          "gender minority cancer patients", 
          "clinical setting", 
          "population-based cancer registries", 
          "population-based surveillance data", 
          "SOGI data collection", 
          "Cancer Surveillance Program", 
          "stage of disease", 
          "cancer risk factors", 
          "comprehensive cancer center", 
          "minority cancer patients", 
          "survivorship care", 
          "SEER registry", 
          "Cancer Registry", 
          "Cancer Center", 
          "cancer continuum", 
          "standardized data collection", 
          "common cancer", 
          "risk factors", 
          "net hospital", 
          "cancer prevention", 
          "cancer occurrence", 
          "patients", 
          "SGM populations", 
          "mortality trends", 
          "registry", 
          "Aim 2", 
          "surveillance program", 
          "surveillance data", 
          "cisgender population", 
          "population basis", 
          "sexual history", 
          "Aim 1", 
          "organizational-level barriers", 
          "sexual orientation", 
          "cancer research", 
          "incidence", 
          "significant disparities", 
          "SOGI questions", 
          "data collection", 
          "outcomes", 
          "potential utility", 
          "Support Grant", 
          "specific aim", 
          "administrative supplement", 
          "SGM individuals", 
          "population", 
          "disparities", 
          "hospital", 
          "Data System", 
          "cancer", 
          "disease", 
          "setting", 
          "care", 
          "prevention", 
          "gender values", 
          "survival", 
          "sex", 
          "treatment", 
          "burden", 
          "NIH", 
          "surveillance", 
          "supplements", 
          "medicine", 
          "training", 
          "implementation process", 
          "gender", 
          "data", 
          "providers", 
          "aim", 
          "barriers", 
          "facilitators", 
          "individuals", 
          "use", 
          "National Academy", 
          "ultimate goal", 
          "items", 
          "full integration", 
          "factors", 
          "history", 
          "center", 
          "data fields", 
          "occurrence", 
          "collection", 
          "lack", 
          "date", 
          "pilot", 
          "utility", 
          "SOGI", 
          "need", 
          "research", 
          "program", 
          "stage", 
          "practice", 
          "Academy", 
          "USC", 
          "basis", 
          "grants", 
          "intersection", 
          "implementation", 
          "evaluates", 
          "results", 
          "orientation", 
          "trends", 
          "questions", 
          "challenges", 
          "goal", 
          "efforts", 
          "science", 
          "Norris", 
          "values", 
          "viable solution", 
          "form", 
          "tabs", 
          "continuum", 
          "integration", 
          "Abstract", 
          "optional form", 
          "system", 
          "data items", 
          "process", 
          "existence", 
          "field", 
          "solution", 
          "engineering", 
          "voluntary collection"
        ], 
        "name": "Administrative Supplements for the P30 Cancer Center Support Grants to Enhance Sexual Orientation and Gender Identity (SOGI) Data Collection", 
        "recipient": [
          {
            "id": "http://www.grid.ac/institutes/grid.42505.36", 
            "type": "Organization"
          }, 
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/None", 
              "name": "UNIVERSITY OF SOUTHERN CALIFORNIA", 
              "type": "Organization"
            }, 
            "familyName": "LERMAN", 
            "givenName": "CARYN", 
            "id": "sg:person.010214013137.28", 
            "type": "Person"
          }, 
          {
            "member": "sg:person.010214013137.28", 
            "roleName": "PI", 
            "type": "Role"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/details/grant/grant.2438805"
        ], 
        "sdDataset": "grants", 
        "sdDatePublished": "2022-12-01T06:58", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/grant/grant_64.jsonl", 
        "startDate": "1980-04-01", 
        "type": "MonetaryGrant", 
        "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=10641590"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2438805'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2438805'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2438805'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2438805'


     

    This table displays all metadata directly associated to this object as RDF triples.

    175 TRIPLES      18 PREDICATES      151 URIs      143 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:grant.2438805 schema:about anzsrc-for:42
    2 schema:amount N5dccaeb9ac8a44ea96635e0970c80791
    3 schema:description Abstract Compared to heterosexual and cisgender populations, SGM populations face disparities related to cancer occurrence and outcomes, including barriers in cancer prevention, treatment, and survivorship care, and significant disparities in cancer risk factors. Despite these disparities, SGM cancer research is hampered by a lack of sexual orientation and gender identity (SOGI) data collection in clinical settings and in population-based surveillance data (especially cancer registries), and as a result, incidence, and mortality trends for SGM populations are difficult to document. The National Academies of Science, Engineering, and Medicine recently recommended that the NIH adopt standardized and parsimonious practices for collecting data on sex, gender, and sexual orientation to address these challenges. The USC/Norris Comprehensive Cancer Center (NCCC) adopted standardized data collection for SOGI during 2018 across its data systems (at the central hospital and outlying clinics), but those data are collected in optional forms in a “Social/Sexual History” tab, and to date there has been no effort to determine how complete or representative those data are. NCCC evaluates and treats cancer patients from Los Angeles County’s safety net hospital (LAC/USC), which also adopted voluntary collection of SOGI data fields in 2018. Provider training in the existence and use of SOGI data items has been provided on an ad hoc basis. To evaluate the potential utility of these data in advancing SGM research across the cancer continuum, we propose the following Specific Aims: Aim 1. Study the implementation of standardized SOGI data collection at NCCC Aim 2. Assess patient-, provider-, and clinic/organizational-level barriers and facilitators toward implementation of standardized SOGI data collection by surveying patients who did, and did not, answer SOGI questions. Aim 3. Link LAC/USC and USC/Norris records to the Los Angeles Cancer Surveillance Program (LA’s SEER Registry) and describe the intersection of patient-reported SOGI data items and Registry-based gender (Male/Female/Other/Unknown) values, as well as the burden of common cancers among gender minority cancer patients, comparing incidence, stage of disease, and survival of those patients whose SOGI was misclassified in the Registry. Aim 4. Pilot and evaluate provider training in SOGI data collection. Our ultimate goal will be to document implementation processes and identify and pilot viable solutions to support full integration and use of standardized SOGI data collection in the clinical setting to support surveillance and research. By linking data with the LA SEER registry, we will be able to document the need for including SOGI data collection in population-based cancer registries and begin to track outcomes for SGM individuals on a population basis.
    4 schema:endDate 2026-11-30
    5 schema:funder grid-institutes:grid.48336.3a
    6 schema:identifier N0b01d84e98674b7dba507ff11a72ce80
    7 N1f33e12e9dd44070b722843700002647
    8 schema:keywords Abstract
    9 Academy
    10 Aim 1
    11 Aim 2
    12 Cancer Center
    13 Cancer Registry
    14 Cancer Surveillance Program
    15 Data System
    16 Los Angeles Cancer Surveillance Program
    17 NIH
    18 National Academy
    19 Norris
    20 SEER registry
    21 SGM individuals
    22 SGM populations
    23 SOGI
    24 SOGI data collection
    25 SOGI questions
    26 Support Grant
    27 USC
    28 administrative supplement
    29 aim
    30 barriers
    31 basis
    32 burden
    33 cancer
    34 cancer continuum
    35 cancer occurrence
    36 cancer patients
    37 cancer prevention
    38 cancer research
    39 cancer risk factors
    40 care
    41 center
    42 challenges
    43 cisgender population
    44 clinical setting
    45 collection
    46 common cancer
    47 comprehensive cancer center
    48 continuum
    49 county safety-net hospital
    50 data
    51 data collection
    52 data fields
    53 data items
    54 date
    55 disease
    56 disparities
    57 efforts
    58 engineering
    59 evaluates
    60 existence
    61 facilitators
    62 factors
    63 field
    64 form
    65 full integration
    66 gender
    67 gender identity data collection
    68 gender minority cancer patients
    69 gender values
    70 goal
    71 grants
    72 history
    73 hospital
    74 implementation
    75 implementation process
    76 incidence
    77 individuals
    78 integration
    79 intersection
    80 items
    81 lack
    82 medicine
    83 minority cancer patients
    84 mortality trends
    85 need
    86 net hospital
    87 occurrence
    88 optional form
    89 organizational-level barriers
    90 orientation
    91 outcomes
    92 patients
    93 pilot
    94 population
    95 population basis
    96 population-based cancer registries
    97 population-based surveillance data
    98 potential utility
    99 practice
    100 prevention
    101 process
    102 program
    103 provider training
    104 providers
    105 questions
    106 registry
    107 research
    108 results
    109 risk factors
    110 safety-net hospital
    111 science
    112 setting
    113 sex
    114 sexual history
    115 sexual orientation
    116 significant disparities
    117 solution
    118 specific aim
    119 stage
    120 stage of disease
    121 standardized data collection
    122 supplements
    123 surveillance
    124 surveillance data
    125 surveillance program
    126 survival
    127 survivorship care
    128 system
    129 tabs
    130 training
    131 treatment
    132 trends
    133 ultimate goal
    134 use
    135 utility
    136 values
    137 viable solution
    138 voluntary collection
    139 schema:name Administrative Supplements for the P30 Cancer Center Support Grants to Enhance Sexual Orientation and Gender Identity (SOGI) Data Collection
    140 schema:recipient N3254bca82e9641aa929c837077f72379
    141 sg:person.010214013137.28
    142 grid-institutes:grid.42505.36
    143 schema:sameAs https://app.dimensions.ai/details/grant/grant.2438805
    144 schema:sdDatePublished 2022-12-01T06:58
    145 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    146 schema:sdPublisher Nd097e8d0b1c4450f9a8573f2b8bac9f5
    147 schema:startDate 1980-04-01
    148 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=10641590
    149 sgo:license sg:explorer/license/
    150 sgo:sdDataset grants
    151 rdf:type schema:MonetaryGrant
    152 N0b01d84e98674b7dba507ff11a72ce80 schema:name dimensions_id
    153 schema:value grant.2438805
    154 rdf:type schema:PropertyValue
    155 N1f33e12e9dd44070b722843700002647 schema:name nih_id
    156 schema:value P30CA014089
    157 rdf:type schema:PropertyValue
    158 N3254bca82e9641aa929c837077f72379 schema:member sg:person.010214013137.28
    159 schema:roleName PI
    160 rdf:type schema:Role
    161 N5dccaeb9ac8a44ea96635e0970c80791 schema:currency USD
    162 schema:value 198147648.0
    163 rdf:type schema:MonetaryAmount
    164 Nd097e8d0b1c4450f9a8573f2b8bac9f5 schema:name Springer Nature - SN SciGraph project
    165 rdf:type schema:Organization
    166 anzsrc-for:42 schema:inDefinedTermSet anzsrc-for:
    167 rdf:type schema:DefinedTerm
    168 sg:person.010214013137.28 schema:affiliation grid-institutes:None
    169 schema:familyName LERMAN
    170 schema:givenName CARYN
    171 rdf:type schema:Person
    172 grid-institutes:None schema:name UNIVERSITY OF SOUTHERN CALIFORNIA
    173 rdf:type schema:Organization
    174 grid-institutes:grid.42505.36 schema:Organization
    175 grid-institutes:grid.48336.3a schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...